WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dalman, F. C.
Right arrow Articles by O'Malley, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dalman, F. C.
Right arrow Articles by O'Malley, K. L.

 Previous Article  |  Next Article 

The Journal of Neuroscience, July 15, 1999, 19(14):5750-5757

kappa -Opioid Tolerance and Dependence in Cultures of Dopaminergic Midbrain Neurons

Friedrich C. Dalman1 and Karen L. O'Malley2

Departments of 1 Anesthesiology and 2 Anatomy & Neurobiology, Washington University School of Medicine, St. Louis, Missouri 63110

Repeated cocaine exposure upregulates kappa  opioids and their receptors in the mesocorticolimbic system; the ensuing kappa -mediated dysphoria appears to contribute to addiction and withdrawal. As a potential rehabilitation strategy to reverse cocaine-induced kappa  sensitization, the present study used tritiated dopamine release assays to examine the induction of kappa -opioid tolerance in cultured mesencephalic neurons. Administration of the kappa  agonist U69,593 inhibited tetrodotoxin-sensitive, spontaneous (EC50 = 1.5 nM), and potassium-stimulated (EC50 = 10 nM) release. These effects were blocked by pertussis toxin and by the kappa  antagonist nor-binaltorphimine. The 2 d agonist exposure (1 µM) caused a shift in the U69,593 dose-response curve that was greater in the potassium-stimulated paradigm (140-fold) than in the spontaneous release assay (sixfold). These results were attributable to the attenuation of kappa -receptor signaling mechanisms and to dependence. In the stimulated release assay, attenuation of kappa  signaling caused by 4 hr of U69,593 exposure recovered with a half-life of 1.1 hr, whereas attenuation after 144 hr of exposure recovered slowly (t1/2 = 20 hr). In the spontaneous release assay, attenuation of kappa -opioid signaling occurred slowly (t1/2 = 22 hr), and resensitization after a 144 hr exposure was rapid (t1/2 < 1 hr). kappa -Opioid dependence was observed after 144 hr of U69,593 exposure. Thus multiple mechanisms of adaptation to kappa -opioid exposure occur in mesocorticolimbic neurons. These data support the idea that the administration of kappa  opioids might facilitate drug rehabilitation.

Key words: kappa -opioid receptor; tolerance; dependence; mesencephalon; dopaminergic neurons; primary neuronal culture; neurotransmitter release; U69,593


Copyright © 1999 Society for Neuroscience  0270-6474/99/19145750-08$05.00/0


This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
C. P. Ford, M. J. Beckstead, and J. T. Williams
Kappa Opioid Inhibition of Somatodendritic Dopamine Inhibitory Postsynaptic Currents
J Neurophysiol, January 1, 2007; 97(1): 883 - 891.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. P. Ford, G. P. Mark, and J. T. Williams
Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location.
J. Neurosci., March 8, 2006; 26(10): 2788 - 2797.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. B. Margolis, G. O. Hjelmstad, A. Bonci, and H. L. Fields
{kappa}-Opioid Agonists Directly Inhibit Midbrain Dopaminergic Neurons
J. Neurosci., November 5, 2003; 23(31): 9981 - 9986.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
N. D. Mazarakis, M. Azzouz, J. B. Rohll, F. M. Ellard, F. J. Wilkes, A. L. Olsen, E. E. Carter, R. D. Barber, D. F. Baban, S. M. Kingsman, et al.
Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery
Hum. Mol. Genet., September 1, 2001; 10(19): 2109 - 2121.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. T. Williams, M. J. Christie, and O. Manzoni
Cellular and Synaptic Adaptations Mediating Opioid Dependence
Physiol Rev, January 1, 2001; 81(1): 299 - 343.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-